GAYLE LOMBARD: Open Payments
NPI 1942688320 · ALBERTVILLE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$457 in 20 payments from 11 companies in 2025. Trend: 2023 $1,953 · 2024 $771 · 2025 $457
Food & beverage: $457
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 4 | $165 |
| Exact Sciences Corporation | 4 | $58 |
| Indivior Inc. | 2 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| ABBVIE INC. | 1 | $23 |
| Lilly USA, LLC | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $17 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
Products named: RECORLEV, SUBLOCADE, Cologuard Collection Kit, Kerendia, QULIPTA, MOUNJARO, XIFAXAN, JOURNAVX.
Industry payments across AL — which companies pay providers there.
